editorial | Q871232 |
scholarly article | Q13442814 |
P50 | author | Alvaro Lassaletta | Q60601162 |
P2093 | author name string | Vijay Ramaswamy | |
P2860 | cites work | Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase | Q26784116 |
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition | Q27852966 | ||
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. | Q27853187 | ||
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct | Q35960250 | ||
Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients? | Q36493799 | ||
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus | Q36901551 | ||
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma | Q37316068 | ||
Patterns of care in adult medulloblastoma: results of an international online survey | Q39159565 | ||
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449 | Q42031842 | ||
Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts | Q43671177 | ||
Adult medulloblastoma comprises three major molecular variants. | Q55463035 | ||
Long-term results of a prospective study on the treatment of medulloblastoma in adults. | Q55467796 | ||
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. | Q55475283 | ||
P433 | issue | 7 | |
P921 | main subject | medulloblastoma | Q1333608 |
P304 | page(s) | 895-897 | |
P577 | publication date | 2016-07-01 | |
P1433 | published in | Neuro-Oncology | Q15724471 |
P1476 | title | Medulloblastoma in adults: they're not just big kids | |
P478 | volume | 18 |
Q38629781 | Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype. |
Q64087873 | Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas |
Q92865416 | Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches |
Search more.